Shanghai Hile Bio-tech (603718) — Capital Reinvestment Ratio

Latest as of June 2025: 0.06x

Shanghai Hile Bio-tech (603718) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥43.72 Million) in capital expenditures (CN¥2.64 Million). See 603718 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥43.72 Million
CNY

Capital Expenditures

CN¥2.64 Million
CNY

Data as of

Jun 2025
Most recent filing

Shanghai Hile Bio-tech Capital Reinvestment Ratio (2011–2025)

This chart tracks Shanghai Hile Bio-tech's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Shanghai Hile Bio-tech (2011–2025)

Year-by-year Capital Reinvestment Ratio for Shanghai Hile Bio-tech from 2011 to 2025. For live market cap and broader valuation context, see market cap of Shanghai Hile Bio-tech.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.21x CN¥58.83 Million CN¥12.17 Million ▲ +14.6%
2024 0.18x CN¥46.47 Million CN¥8.39 Million ▲ +166.5%
2022 0.07x CN¥292.91 Million CN¥19.85 Million ▼ -92.2%
2021 0.87x CN¥43.63 Million CN¥37.78 Million ▲ +325.5%
2020 0.20x CN¥167.68 Million CN¥34.12 Million ▼ -69.1%
2019 0.66x CN¥59.25 Million CN¥39.03 Million ▼ -88.9%
2018 5.94x CN¥18.92 Million CN¥112.29 Million ▲ +140.9%
2017 2.46x CN¥34.92 Million CN¥86.04 Million ▲ +96.1%
2016 1.26x CN¥108.39 Million CN¥136.16 Million ▲ +82.0%
2015 0.69x CN¥201.69 Million CN¥139.18 Million ▼ -12.6%
2014 0.79x CN¥110.22 Million CN¥87.07 Million ▲ +369.2%
2013 0.17x CN¥147.63 Million CN¥24.86 Million ▼ -40.4%
2012 0.28x CN¥122.48 Million CN¥34.58 Million ▼ -18.2%
2011 0.35x CN¥149.61 Million CN¥51.64 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow